Syncardia Total Artificial Heart

The Syncardia Total Artifical Heart is an implanted, pulsatile flow device that is FDA approved for bridge-to-transplantation in patients with biventricular (left and right) heart failure. The system is driven by a pneumatic (air) pump. USC was the first center in Los Angeles to implant a Total Artifical Heart, and the first center on the West Coast to enroll a patient in the clinical trial involving the miniaturized, portable, Freedom Driver which allows patients with the Total Artifical Heart increased mobility, and the option of returning home. For more information please visit www.syncardia.com.